Avian influenza virus miRNA, and appraisal, detection, and application thereof
AssigneeJiangsu Micromedmark Biotech Co., Ltd.
InventorsChenyu Zhang, Ke Zeng, Jin Wang, Xihan Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeJiangsu Micromedmark Biotech Co., Ltd.
InventorsChenyu Zhang, Ke Zeng, Jin Wang, Xihan Li
Estimating the term…
The present invention relates to an avian influenza virus miRNA and the identification, detection and application thereof. In particular, a kind of specific microRNA, miR-HA-3p, is screened for the first time through detecting the microRNA expression levels in samples of animals with avian influenza. The experiments prove that the miR-HA-3p, as a microRNA marker, can be very effective in detecting avian influenza virus and avian influenza. Furthermore, inhibiting the function of miR-HA-3p can be very effective in relieving symptoms of avian influenza and treating avian influenza. The microRNA revealed in the present invention for the first time can be developed into a detection agent and a therapeutic agent as well as the corresponding kits for the detection and treatment of avian influenza (e.g., H5N1).
A chemically modified single stranded small RNA, which is a complementary miRNA and is completely complementary to a nucleotide sequence selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.